Kleanthis Xanthopoulos Insider Profile

4 Followers
Kleanthis Xanthopoulos, President & CEO, Director at Regulus, holds 23.60K shares in Zosano Pharma (Ticker: ZSANQ), holds 55.73K shares in Seelos Therapeutics (Ticker: SEEL), holds 83.92K shares in Regulus (Ticker: RGLS).
tipranks
Kleanthis Xanthopoulos

Kleanthis Xanthopoulos
Regulus (RGLS)
President & CEO, Director

Ranked #77,685 out of 98,042 Corporate Insiders

Profitable Transactions

17%
1 out of 6 Profitable Transactions

Average Return

-17.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$174K
85.90%
14.10%
0.00%
A breakdown of Kleanthis Xanthopoulos's holdings

Insider Roles

Regulus
(RGLS)
President & CEO, Director
Seelos Therapeutics
(SEEL)
Director
Ionis Pharmaceuticals
(IONS)
President of Regulus
Roles that Kleanthis Xanthopoulos holds in companies

Most Profitable Insider Trade

Stock:
Regulus
(RGLS)
Rating:Informative Sell
Date:Oct 14, 2014 - Oct 14, 2015
Return:+6.20%
The most profitable trade made by Kleanthis Xanthopoulos

Kleanthis Xanthopoulos's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Regulus
Apr 21, 2015
President & CEO, Director
Uninformative Sell
3.43M
$149.38K
ZSANQ
Zosano Pharma
Jun 14, 2021
Uninformative Buy
$471.92
Seelos Therapeutics
Jan 06, 2017
Director
Uninformative Buy
$24.52K
Ionis Pharmaceuticals
President of Regulus
$0.00
List of latest transactions for each holding click on a transaction to see Kleanthis Xanthopoulos's performance on stock

Kleanthis Xanthopoulos insider profile FAQ

What is the percentage of profitable transactions made by Kleanthis Xanthopoulos?
The percentage of profitable transactions made by Kleanthis Xanthopoulos is 17%.
    What is the average return per transaction made by Kleanthis Xanthopoulos?
    The average return per transaction made by Kleanthis Xanthopoulos is -17.90%.
      What stocks does Kleanthis Xanthopoulos hold?
      Kleanthis Xanthopoulos holds: RGLS, ZSANQ, SEEL, IONS stocks.
        What was Kleanthis Xanthopoulos’s latest transaction?
        Kleanthis Xanthopoulos latest transaction was an Uninformative Buy of ―.
          What was Kleanthis Xanthopoulos's most profitable transaction?
          Kleanthis Xanthopoulos’s most profitable transaction was an Informative Sell of RGLS stock on October 14, 2014. The return on the trade was 6.20%.
            What is Kleanthis Xanthopoulos's role in Regulus?
            Kleanthis Xanthopoulos's role in Regulus is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.